ARTICLE
16 August 2024

Combatting Antimicrobial Resistance

MC
Marks & Clerk

Contributor

Marks & Clerk is one of the UK’s foremost firms of Patent and Trade Mark Attorneys. Our attorneys and solicitors are wired directly into the UK’s leading business and innovation economies. Alongside this we have offices in 9 international locations covering the EU, Canada and Asia, meaning we offer clients the best possible service locally, nationally and internationally.
Antimicrobial resistance, or AMR, is one of the major current health concerns. Resistant strains which have emerged recently include gonorrhoea, tuberculosis, MRSA, and even the bubonic plague.
United Kingdom Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Antimicrobial resistance, or AMR, is one of the major current health concerns. Resistant strains which have emerged recently includegonorrhoea,tuberculosis,MRSA, and even thebubonic plague. There is also thepotential impact of SARS-CoV-2on the development of AMR, just to add to the mix.

Obviously there are many global initiatives devoted to tackling the problem, andthis feature fromNaturedescribes five key ways in which this is approached. Interestingly, not all are about developing new drugs - changing the way we treat infections is also key.

The five include:

  1. Looking for new drugs - especially from hard-to-culture bacteria
  2. Using AI
  3. New cocktails of drugs
  4. Improving patient response
  5. Better rapid diagnosis

Notably, this last was the subject of the winner of theAMR Longitude Prize, which we coveredhere.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More